BioCentury | Sep 10, 2007
Company News

Concateno, Cozart deal

...Stewart is advising COT, and Numis Securities is advising CZT. Concateno plc (LSE:COT), London, U.K. Cozart plc...
BioCentury | Mar 12, 2007
Company News

Cozart, Nemesis Scientific Ltd. deal

...provides workplace drug and alcohol testing services and products, including CZT's RapiScan saliva-based test system. Cozart plc...
BioCentury | May 22, 2006
Company News

Cozart sales and marketing update

...CZT launched its Cozart drug detection system (DDS), which uses saliva to test for cannabis, ecstasy...
...detection system (DDS), which uses saliva to test for cannabis, ecstasy, methamphetamine, methadone and amphetamine. Cozart plc...
BioCentury | May 15, 2006
Company News

Cozart diagnostic news

...a national DNA database. CZT said the four-year contract is worth £2 million ($3.6 million). Cozart plc...
BioCentury | Nov 21, 2005
Company News

Cozart board of directors update

Cozart plc (LSE:CZT), Abingdon, U.K. Business: Diagnostic Appointed: Chris Yates, CZT's finance director WIR Staff...
BioCentury | Nov 21, 2005
Company News

Cozart management update

Cozart plc (LSE:CZT), Abingdon, U.K. Business: Diagnostic Transitioned: Philip Hand to director of business development from finance and commercial director; and Katherine Wright to company secretary, while remaining head of finance WIR Staff Diagnostic...
BioCentury | Oct 24, 2005
Company News

Cozart board of directors update

Cozart plc (LSE:CZT), Abingdon, U.K. Business: Diagnostic Appointed: Paul Kennedy, a company consultant WIR Staff Diagnostic...
BioCentury | Oct 10, 2005
Company News

Cozart, Spinreact S.A. deal

...profit of E1.2 million ($1.4 million) on sales of E8.6 million ($10.4 million) last year. Cozart plc...
BioCentury | Apr 29, 2002
Company News

Cozart Biosciences Ltd. sales and marketing update

...Cozart launched its RapiScan Buprenorphine test to monitor individuals' compliance with treatment for opiate abuse. Cozart...
BioCentury | Mar 25, 2002
Company News

Cozart Bioscience Ltd. management update

Cozart Bioscience Ltd., Abingdon, U.K. Business: Diagnostics/Imaging Hired: David McGough as international business development manager, formerly European sales manager at LifePoint Inc. WIR Staff Diagnostic...
Items per page:
1 - 10 of 12
BioCentury | Sep 10, 2007
Company News

Concateno, Cozart deal

...Stewart is advising COT, and Numis Securities is advising CZT. Concateno plc (LSE:COT), London, U.K. Cozart plc...
BioCentury | Mar 12, 2007
Company News

Cozart, Nemesis Scientific Ltd. deal

...provides workplace drug and alcohol testing services and products, including CZT's RapiScan saliva-based test system. Cozart plc...
BioCentury | May 22, 2006
Company News

Cozart sales and marketing update

...CZT launched its Cozart drug detection system (DDS), which uses saliva to test for cannabis, ecstasy...
...detection system (DDS), which uses saliva to test for cannabis, ecstasy, methamphetamine, methadone and amphetamine. Cozart plc...
BioCentury | May 15, 2006
Company News

Cozart diagnostic news

...a national DNA database. CZT said the four-year contract is worth £2 million ($3.6 million). Cozart plc...
BioCentury | Nov 21, 2005
Company News

Cozart board of directors update

Cozart plc (LSE:CZT), Abingdon, U.K. Business: Diagnostic Appointed: Chris Yates, CZT's finance director WIR Staff...
BioCentury | Nov 21, 2005
Company News

Cozart management update

Cozart plc (LSE:CZT), Abingdon, U.K. Business: Diagnostic Transitioned: Philip Hand to director of business development from finance and commercial director; and Katherine Wright to company secretary, while remaining head of finance WIR Staff Diagnostic...
BioCentury | Oct 24, 2005
Company News

Cozart board of directors update

Cozart plc (LSE:CZT), Abingdon, U.K. Business: Diagnostic Appointed: Paul Kennedy, a company consultant WIR Staff Diagnostic...
BioCentury | Oct 10, 2005
Company News

Cozart, Spinreact S.A. deal

...profit of E1.2 million ($1.4 million) on sales of E8.6 million ($10.4 million) last year. Cozart plc...
BioCentury | Apr 29, 2002
Company News

Cozart Biosciences Ltd. sales and marketing update

...Cozart launched its RapiScan Buprenorphine test to monitor individuals' compliance with treatment for opiate abuse. Cozart...
BioCentury | Mar 25, 2002
Company News

Cozart Bioscience Ltd. management update

Cozart Bioscience Ltd., Abingdon, U.K. Business: Diagnostics/Imaging Hired: David McGough as international business development manager, formerly European sales manager at LifePoint Inc. WIR Staff Diagnostic...
Items per page:
1 - 10 of 12